YU115279A - Process for obtaining new 4-amino-2-piperidino quinazoline derivatives - Google Patents
Process for obtaining new 4-amino-2-piperidino quinazoline derivativesInfo
- Publication number
- YU115279A YU115279A YU01152/79A YU115279A YU115279A YU 115279 A YU115279 A YU 115279A YU 01152/79 A YU01152/79 A YU 01152/79A YU 115279 A YU115279 A YU 115279A YU 115279 A YU115279 A YU 115279A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- piperidino
- amino
- quinazoline derivatives
- obtaining new
- quinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2035178 | 1978-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU115279A true YU115279A (en) | 1983-04-30 |
Family
ID=10144517
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU01152/79A YU115279A (en) | 1978-05-18 | 1979-05-16 | Process for obtaining new 4-amino-2-piperidino quinazoline derivatives |
YU02563/82A YU256382A (en) | 1978-05-18 | 1982-11-16 | Process for obtaining new 4-amino-2-piperidino quinazoline derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU02563/82A YU256382A (en) | 1978-05-18 | 1982-11-16 | Process for obtaining new 4-amino-2-piperidino quinazoline derivatives |
Country Status (30)
Country | Link |
---|---|
US (1) | US4243666A (xx) |
JP (1) | JPS554370A (xx) |
AR (2) | AR223487A1 (xx) |
AT (1) | ATA363379A (xx) |
AU (1) | AU512947B2 (xx) |
BE (1) | BE876297A (xx) |
CA (1) | CA1240325A (xx) |
CH (1) | CH643553A5 (xx) |
CS (1) | CS214796B2 (xx) |
DD (1) | DD143613A5 (xx) |
DE (1) | DE2919800A1 (xx) |
DK (1) | DK159079A (xx) |
ES (2) | ES480671A1 (xx) |
FI (1) | FI64589C (xx) |
FR (1) | FR2434162A1 (xx) |
GR (1) | GR72824B (xx) |
HU (1) | HU182562B (xx) |
IL (1) | IL57297A (xx) |
IN (1) | IN153045B (xx) |
IT (1) | IT1114222B (xx) |
LU (1) | LU81284A1 (xx) |
NL (1) | NL172157C (xx) |
NO (1) | NO791648L (xx) |
NZ (1) | NZ190465A (xx) |
PH (1) | PH14802A (xx) |
PL (2) | PL121158B1 (xx) |
PT (1) | PT69622A (xx) |
SE (1) | SE439306B (xx) |
YU (2) | YU115279A (xx) |
ZA (1) | ZA792390B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
JPS5962766U (ja) * | 1982-06-30 | 1984-04-25 | 守田 智 | 小動物用給水器 |
GB8414518D0 (en) * | 1984-06-07 | 1984-07-11 | Pfizer Ltd | Therapeutic agents |
US5801195A (en) * | 1994-12-30 | 1998-09-01 | Celgene Corporation | Immunotherapeutic aryl amides |
US6248888B1 (en) | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
CN1494529A (zh) * | 2001-01-18 | 2004-05-05 | 武田药品工业株式会社 | 苄基哌啶化合物的制备方法 |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
EP1685115A1 (en) * | 2003-11-03 | 2006-08-02 | Warner-Lambert Company LLC | Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
CL2007002958A1 (es) * | 2006-10-12 | 2008-05-09 | Epix Delaware Inc | Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr |
EP2139868B1 (en) * | 2007-04-04 | 2015-07-29 | Cipla Limited | Process for preparation of erlotinib and its pharmaceutically acceptable salts |
AU2008335135A1 (en) * | 2007-12-11 | 2009-06-18 | Cytopathfinder, Inc. | Carboxamide compounds and their use as chemokine receptor agonists |
ES2404076T3 (es) * | 2008-11-14 | 2013-05-23 | F. Hoffmann-La Roche Ag | Derivados quinazolina como antagonistas del receptor de NK3 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
FR2321890A1 (fr) * | 1975-08-26 | 1977-03-25 | Synthelabo | Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment |
DK140695C (da) * | 1976-05-07 | 1980-05-12 | Synthelabo | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf |
-
1979
- 1979-04-18 DK DK159079A patent/DK159079A/da not_active IP Right Cessation
- 1979-05-14 US US06/038,509 patent/US4243666A/en not_active Expired - Lifetime
- 1979-05-16 BE BE0/195197A patent/BE876297A/xx unknown
- 1979-05-16 IL IL57297A patent/IL57297A/xx unknown
- 1979-05-16 NO NO791648A patent/NO791648L/no unknown
- 1979-05-16 PL PL1979223844A patent/PL121158B1/pl unknown
- 1979-05-16 GR GR59104A patent/GR72824B/el unknown
- 1979-05-16 YU YU01152/79A patent/YU115279A/xx unknown
- 1979-05-16 PH PH22500A patent/PH14802A/en unknown
- 1979-05-16 NL NLAANVRAGE7903853,A patent/NL172157C/xx not_active IP Right Cessation
- 1979-05-16 DE DE19792919800 patent/DE2919800A1/de not_active Ceased
- 1979-05-16 NZ NZ190465A patent/NZ190465A/xx unknown
- 1979-05-16 IT IT22720/79A patent/IT1114222B/it active
- 1979-05-16 CS CS793372A patent/CS214796B2/cs unknown
- 1979-05-16 AT AT0363379A patent/ATA363379A/de not_active IP Right Cessation
- 1979-05-16 FI FI791562A patent/FI64589C/fi not_active IP Right Cessation
- 1979-05-16 AR AR276536A patent/AR223487A1/es active
- 1979-05-16 AU AU47101/79A patent/AU512947B2/en not_active Ceased
- 1979-05-16 IN IN337/DEL/79A patent/IN153045B/en unknown
- 1979-05-16 PL PL1979215626A patent/PL120651B1/pl unknown
- 1979-05-17 HU HU79PI678A patent/HU182562B/hu unknown
- 1979-05-17 CA CA000327839A patent/CA1240325A/en not_active Expired
- 1979-05-17 FR FR7912635A patent/FR2434162A1/fr active Granted
- 1979-05-17 SE SE7904358A patent/SE439306B/sv not_active IP Right Cessation
- 1979-05-17 JP JP6100079A patent/JPS554370A/ja active Granted
- 1979-05-17 PT PT69622A patent/PT69622A/pt unknown
- 1979-05-17 LU LU81284A patent/LU81284A1/fr unknown
- 1979-05-17 ES ES480671A patent/ES480671A1/es not_active Expired
- 1979-05-17 CH CH459879A patent/CH643553A5/de not_active IP Right Cessation
- 1979-05-17 ZA ZA792390A patent/ZA792390B/xx unknown
- 1979-05-18 DD DD79213010A patent/DD143613A5/de unknown
-
1980
- 1980-02-01 ES ES488210A patent/ES8101584A1/es not_active Expired
- 1980-10-28 AR AR283021A patent/AR224784A1/es active
-
1982
- 1982-11-16 YU YU02563/82A patent/YU256382A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU5079A (en) | Process for obtaining new 4-amino-5-alkyl-sulfony-orthoismide derivatives | |
YU43532B (en) | Process for obtaining carboxyalkyldipeptides derivatives | |
YU42064B (en) | Process for obtaining new glycevol derivatives | |
YU93179A (en) | Process for obtaining 4-deacetyl-vinca-leublastin c-3-carboxhydrazide | |
PT71512B (en) | Process for preparing quinazoline derivatives | |
YU61679A (en) | Process for obtaining new flavanes | |
YU84179A (en) | Process for obtaining 2-aminopyridone derivatives | |
YU256382A (en) | Process for obtaining new 4-amino-2-piperidino quinazoline derivatives | |
YU80179A (en) | Process for obtaining lysergol derivatives | |
YU42653B (en) | Process for obtaining n-benzylhaloacetamide derivatives | |
YU198879A (en) | New process for obtaining benzothiazyl-disulfide | |
YU241279A (en) | Process for obtaining 2-chlorosulfinyl-azetidine-4-one | |
YU145480A (en) | Process for obtaining new hydroxyamino-eburnane derivatives | |
PT71902A (en) | Process for preparing quinazoline derivatives | |
PT70407A (en) | Process for preparing new aryltrifluoroethanol derivatives | |
YU73579A (en) | Process for obtaining steroid-spiro-oxazolidinone derivatives | |
PT67821B (en) | Process for preparing quinazoline derivatives | |
YU112279A (en) | Process for obtaining substituted dibenzylethers | |
YU210180A (en) | Process for obtaining new pyrimidone derivatives | |
YU86879A (en) | Process for obtaining 17-beta-carboxy-5-androstane-3-one | |
YU219379A (en) | Process for obtaining new 1-benzoyl-3-thiosemicarbazide | |
YU42675B (en) | Process for obtaining new nitroalkanol derivatives | |
YU100280A (en) | Process for obtaining new aminoisoquinazoline derivatives | |
YU105179A (en) | Process for obtaining new deoxyanthracyclins | |
YU258179A (en) | New process for obtaining benzothiazole-sulfenamide |